These DUX4-FL targets are misregulated in FSHD and, although the mechanisms are still unclear, it is thought that aberrant expression of one or more of these targets ultimately lead to accumulated muscle pathology [29–31]. The gene discussed is FLT3LG; the disease is facioscapulohumeral muscular dystrophy.